-
Charnwood Molecular Plans Significant Expansion
contractpharma
April 29, 2021
Charnwood Molecular, a UK-based preclinical discovery CRO servicing the global pharmaceutical and biopharma market, is planning a significant expansion in 2021.
-
Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index
prnasia
March 09, 2021
Global life sciences leader Cytiva, along with the Financial Times' research arm Longitude, have compiled a global index, ranking the ability of the biopharma industry to respond to five major challenges; in supply chain, talent, research and ...
-
High Purity New England Bolsters Biopharma Solutions Services
contractpharma
February 26, 2021
High Purity New England (HPNE), a manufacturer and distributor of solutions for the biopharma industry, has introduced a highly customizable bioreactor line from BioStream International for the North American market.
-
Value of pharma’s M&A deals remain high, despite COVID-19
europeanpharmaceuticalreview
January 11, 2021
Analysts say M&A deals continue to be a core driver of pharma/biopharma industry growth and that 2021 will likely be another year of high deal value.
-
Healthcare industry records 103 deals worth $55.3 billion in December 2020
expresspharma
January 08, 2021
One big-ticket deal contributes 70.5 per cent of the total deal value in December 2020.
-
Agilent confers Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore
expresspharma
December 08, 2020
Prof Rathore, the first researcher in India to receive this award; has been recognised for his contributions to biopharma research.
-
Regeneron named top biopharma company to work for
europeanpharmaceuticalreview
November 04, 2020
According to Regeneron, it has placed either first or second in the same ranking for the past ten years, making it the most highly ranked company of the decade.
-
Biopharma Leaders Unite To Stand With Science
drugs.com
September 24, 2020
The CEOs today announced a historic pledge, outlining a united commitment to uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.
-
Biopharma increasingly factoring sustainability into cold chain decisions
europeanpharmaceuticalreview
July 31, 2020
A survey has found that the biopharma industry is taking sustainability into their cold chain considerations more and more, with 66 percent saying it is very important.
-
WuXi Biologics to Open Clinical Mfg. Facility in Cranbury, NJ
contractpharma
June 10, 2020
Will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions.